Candesartan cilexetil 16 MG TB 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F9JC9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,805
Award facts
- Contract value 100% obligated
- $11,804.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on December 31, 2025, for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles). The contract is valued at $11,804.52 under a firm fixed-price delivery order with an ultimate completion date of January 2, 2026. This award was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026.
The delivery order supports the Defense Logistics Agency's medical supply chain operations, which procure pharmaceuticals and medical supplies for military healthcare systems and other federal agencies. AmerisourceBergen's DLA IDC encompasses a comprehensive range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The company's consistent receipt of competitive delivery orders demonstrates its capability to meet federal procurement requirements for critical medical commodities supporting Department of Defense healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26F9JC9?
SPE2DR26F9JC9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 31, 2025.
How much is contract SPE2DR26F9JC9 worth?
The government has obligated $11,805 on SPE2DR26F9JC9.
Is contract SPE2DR26F9JC9 an order under another contract?
Yes. SPE2DR26F9JC9 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9JC9 competed?
The extent of competition for SPE2DR26F9JC9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award